Why Cineplex (TSX:CGX) Has Plunged 25% in 2022

Cineplex Inc. (TSX:CGX) stock suffered a sharp drop after it revealed an earnings miss in its second-quarter 2022 report.

| More on:
a person watches a downward arrow crash through the floor

Source: Getty Images

Cineplex (TSX:CGX) is the largest cinema operator in Canada. It boasts a monopoly in an industry that has been severely challenged in recent years, especially during the COVID-19 pandemic. Today, I want to discuss what has caused its stock to run into turbulence in the year-to-date period. Let’s jump in.

What is behind this stock’s struggles in 2022?

Shares of Cineplex have plunged nearly 11% month over month as of close on August 19. The stock is now down 25% in the year-to-date period.

Its long-term shareholders are undoubtedly accustomed to volatility over the last several years. The COVID-19 pandemic presented an existential threat to the movie theatre business. Cineplex was forced to cease its operations for the bulk of 2020 and a good chunk of 2021. Fortunately, an aggressive vaccine push led to a broader reopening from provincial governments, and the company was able to return to normal operations by the spring of this year. That included the removal of the mask mandates in Ontario.

The pandemic may be behind Cineplex, but it is still facing daunting hurdles. Home entertainment alternatives already presented a threat to the future of the movie theatre. Streaming options have now expanded far beyond Netflix. However, this expansion in choice could also lead to apathy among consumers. We have already seen Netflix subscriber numbers stagnate in its recent earnings releases.

This could offer a ray of hope for the future of the cinema. The company and its peers will need to rely on good content and an experience that can entice customers out of their homes.

Should investors be encouraged by Cineplex’s recent earnings?

Cineplex released its second-quarter (Q2) fiscal 2022 results on August 11. The company delivered the strongest quarter of the young decade. That said, it still missed analyst expectations. This sparked a selloff that has worsened into the second half of August.

Total revenues soared 438% year over year to $349 million. Meanwhile, theatre attendance rose to 11.1 million customers compared to a paltry 1.1 million in the second quarter of fiscal 2021. Cineplex and its peers have been bolstered by a strong slate of movie releases. This has included strong box office performances like Top Gun: Maverick, Doctor Strange in the Multiverse of Madness, and Jurassic World Dominion in this most recent quarter.

The company continued to squeeze more value out of its attendees. Box office revenues per patron increased 12% year over year to $12.29. Meanwhile, concession revenues per patron also jumped 12% to $8.84.

Better yet, Cineplex delivered adjusted EBITDA of $35.8 million in Q2 2022 — up from an adjusted EBITDA loss of $53.2 million in the previous year. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA rose to $114 million in the first six months of 2022.

Cineplex: Should you buy on the dip?

This stock is trading in solid value territory relative to its industry peers. Relative Strength Index (RSI) is a technical indicator that measures a given security’s price momentum. Cineplex last had an RSI of 31, which puts this stock just outside of technically oversold territory.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC. and Netflix.

More on Investing

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use Your TFSA to Earn Ultimate Passive Income

If you have a TFSA, then you have the key to creating ultimate passive income. All you need is a…

Read more »

Confused person shrugging
Dividend Stocks

Better Buy: Fortis Stock or Hydro One Stock?

Let's do a compare and contrast of these two top utilities stocks right now, shall we?

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Dividend Stocks

Boost Your Passive Income: 2 Canadian High-Yielders at a Bargain

Nutrien (TSX:NTR) stock and another play that appear like fantastic dividend bargains in mid-November.

Read more »

Super sized rock trucks take a load of platinum rich rock into the crusher.
Metals and Mining Stocks

Invest $7,000 in This Dividend Stock for $672 in Passive Income

High yield can be an essential requirement when you need to start even a modestly sized passive income with a…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »